Evaluation of left ventricular mass measured by 3D echocardiography using magnetic resonance imaging as gold standard

References

• Sheridan D. J. Left ventricular hypertrophy. Churchill Livingstone, London 1998, 1st edn
   Google Scholar
• Kannel W. B., d'Agostino R. B., Levy D., Belanger A. R. Prognostic significance of regression of left ventricular hypertrophy. Circulation 1988; 78(Suppl 2)
   Google Scholar
• Schillaci G., Verdecchia P., Porcellati C., Cuccurullo O., Cosco C., Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000; 35: 580–6
   PubMed Web of Science ®Google Scholar
• Sokolow M., Lyon T. P. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949; 37: 161–85
   PubMed Web of Science ®Google Scholar
• Casale P. N., Devereux R. B., Kligfield P., Eisenberg R. R., Miller D. H., Chaudhary B. S., et al. Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol 1985; 6: 572–80
   PubMed Web of Science ®Google Scholar
• Sundstrom J., Lind L., Arnlov J., Zethelius B., Andren B., Lithell H. O. Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation 2001; 103: 2346–51
   PubMed Web of Science ®Google Scholar
• Romhilt D. W., Bove K. E., Norris R. J., Conyers E., Conradi S., Rowlands D. T., et al. A critical appraisal of the electrocardiographic criteria for the diagnosis of left ventricular hypertrophy. Circulation 1969; 40: 185–95
   PubMed Web of Science ®Google Scholar
• Schiller N. B., Skioldebrand C. G., Schiller E. J., Mavroudis C. C., Silverman N. H., Rahimtoola S. H., et al. Canine left ventricular mass estimation by two‐dimensional echocardiography. Circulation 1983; 68: 210–16
   PubMed Web of Science ®Google Scholar
• Madias J. E. Concealment of electrocardiographically based diagnosis of left ventricular hypertrophy by anasarca. Am J Hypertens 2004; 17: 897–903
   PubMed Web of Science ®Google Scholar
• Casale P. N., Devereux R. B., Alonso D. R., Campo E., Kligfield P. Improved sex‐specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation 1987; 75: 565–72
   PubMed Web of Science ®Google Scholar
• Molloy T. J., Okin P. M., Devereux R. B., Kligfield P. Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage‐duration product. J Am Coll Cardiol 1992; 20: 1180–6
   PubMed Web of Science ®Google Scholar
• Alfakih K., Walters K., Jones T., Ridgway J., Hall A. S., Sivananthan M. New gender‐specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI. Hypertension 2004; 44: 175–9
   PubMed Web of Science ®Google Scholar
• Devereux R. B., Alonso D. R., Lutas E. M., Gottlieb G. J., Campo E., Sachs I., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450–8
   PubMed Web of Science ®Google Scholar
• Devereux R. B., Casale P. N., Wallerson D. C., Kligfield P., Hammond I. W., Liebson P. R., et al. Cost‐effectiveness of echocardiography and electrocardiography for detection of left ventricular hypertrophy in patients with systemic hypertension. Hypertension 1987; 9((2 Pt 2))II69–76
   PubMed Web of Science ®Google Scholar
• Germain P., Roul G., Kastler B., Mossard J. M., Bareiss P., Sacrez A. Inter‐study variability in left ventricular mass measurement. Comparison between M‐mode echography and MRI. Eur Heart J 1992; 13: 1011–19
   PubMed Web of Science ®Google Scholar
• Bottini P. B., Carr A. A., Prisant L. M., Flickinger F. W., Allison J. D., Gottdiener J. S. Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am J Hypertens 1995; 8: 221–8
   PubMed Web of Science ®Google Scholar
• Schiller N. B., Shah P. M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al. Recommendations for quantitation of the left ventricle by two‐dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two‐Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358–67
   PubMed Web of Science ®Google Scholar
• Missouris C. G., Forbat S. M., Singer D. R., Markandu N. D., Underwood R., MacGregor G. A. Echocardiography overestimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension. J Hypertens 1996; 14: 1005–10
   PubMed Web of Science ®Google Scholar
• Bland J. M., Altman D. G. Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol 2003; 22: 85–93
   PubMed Web of Science ®Google Scholar
• Nilas L., Hassager C., Christiansen C. Long‐term precision of dual photon absorptiometry in the lumbar spine in clinical settings. Bone Miner 1988; 3: 305–15
   PubMedGoogle Scholar
• Qin J. X., Jones M., Travaglini A., Song J. M., Li J., White R. D., et al. The accuracy of left ventricular mass determined by real‐time three‐dimensional echocardiography in chronic animal and clinical studies: a comparison with postmortem examination and magnetic resonance imaging. J Am Soc Echocardiogr 2005; 18: 1037–43
   PubMed Web of Science ®Google Scholar
• Okin P. M., Devereux R. B., Jern S., Kjeldsen S. E., Julius S., Nieminen M. S., et al. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study. Circulation 2003; 108: 684–90
   PubMed Web of Science ®Google Scholar
• Gopal A. S., Krishnaswamy R., Joseph S., Toole R., Petillo F., Schapiro W. Comparison of echocardiographic methods to cardiac magnetic resonance imaging for determination of left ventricular mass. ESC Congress 2004, Munich
   Google Scholar
• Mor‐Avi V., Sugeng L., Weinert L., MacEneaney P., Caiani E. G., Koch R., et al. Fast measurement of left ventricular mass with real‐time three‐dimensional echocardiography: comparison with magnetic resonance imaging. Circulation 2004; 110: 1814–18
   PubMed Web of Science ®Google Scholar
• Devereux R. B., Dahlof B., Gerdts E., Boman K., Nieminen M. S., Papademetriou V., et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 2004; 110: 1456–62
   PubMed Web of Science ®Google Scholar
• Lindholm L. H., Ibsen H., Dahlof B., Devereux R. B., Beevers G., de Faire U., et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint Reduction in Hypertension Study (LIFE): a randomised trial against atenolol. Lancet 2002; 359((9311))1004–10
   PubMed Web of Science ®Google Scholar